Author:
Sun Jong-Mu,Nam Mi Hyun,Chung Jae Yong,Im Bohee,Lee Soo-Youn,Suh Youn-Lim,Ahn Jin Seok,Park Keunchil,Ahn Myung-Ju
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference34 articles.
1. Balaban CD, O’Callaghan JP, Billingsley ML (1988) Trimethyltin-induced neuronal damage in the rat brain: comparative studies using silver degeneration stains, immunocytochemistry and immunoassay for neuronotypic and gliotypic proteins. Neuroscience 26:337–361
2. Bleyer WA, Drake JC, Chabner BA (1973) Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia. N Engl J Med 289:770–773
3. Bueno A, De Olmos S, Heimer L, De Olmos J (2003) NMDA-antagonist MK-801-induced neuronal degeneration in Wistar rat brain detected by the Amino-Cupric-Silver method. Exp Toxicol Pathol 54:319–334
4. Chamberlain MC, Kormanik P, Howell SB, Kim S (1995) Pharmacokinetics of intralumbar DTC-101 for the treatment of leptomeningeal metastases. Arch Neurol 52:912–917
5. Chan DC, Chen V, Helfrich B, Zhang Z, Hirsch F, Ma D, Bunn P (2006) Preclinical studies of pemetrexed and gemcitabine, alone and in combinations, in human lung cancers. AACR Meeting Abstracts 2006:1278b